Silicon Valley promises AI will cure disease. Drugmaker CEOs aren't buying It.
Executive Brief • Key Highlights
Fast factual intelligence distilled for busy investors, executives, and answer bots:
- ✓Silicon Valley leaders claim AI will cure most diseases soon, but drugmaker CEOs remain skeptical.
- ✓No AI-designed drug has won FDA clearance yet.
- ✓Vertex executive chairman Jeff Leiden said, "That's complete BS." While companies use AI as a helpful research copilot, they say human biology is far too complicated.
Story at a Glance
- Category
- BUSINESS
- Reported By
- mint
- Reading Speed
- 5 Minute(s)
- Market Focus
- India Economy
Summary
No drug designed by artificial intelligence has won FDA clearance, and pharma leaders say biology is the obstacle.
The promises are grandiose: Anthropic's chief executive said artificial intelligence could cure most human diseases within a decade. Another tech exec joked that AI researchers have started smoking cigarettes because they are so confident AI will cure lung cancer.
Pharma executives don't buy it.
"That's complete BS," said Jeff Leiden, executive chairman of Vertex Pharmaceuticals, recalling a recent conversation with a tech leader who claimed AI would cure 90% of human disease in the next seven years.
Vertex has used roughly 50 AI companies to comb through its data set of 10,000 drug compounds, Leiden said. Not one managed to generate a working drug.
Unlock the Full Story with ArthNow Premium
To continue reading this complete financial story and in-depth market context, upgrade to ArthNow Premium. Enjoy unlimited access across Web and Mobile.
mint
Read the full, original unfiltered story directly on the publisher's portal.